Search for a report

JAPAN JOINT PAIN INJECTIONS MARKET FORECAST 2022-2028

  • You are here:
  • Home
  • Downloads
  • JAPAN JOINT PAIN INJECTIONS MARKET FORECAST 2022-2028

JAPAN JOINT PAIN INJECTIONS MARKET FORECAST 2022-2028

The Japan joint pain injections market is evaluated to develop with a CAGR of 8.57% over the forecast years. The market growth of the country is driven by key factors such as increasing pharmaceutical and biopharmaceutical production, the growing research and development, and the surging prevalence of chronic diseases. The base year considered for the studied market is 2021 and the forecasting period is from 2022 to 2028.

JAPAN JOINT PAIN INJECTIONS MARKET FORECAST 2022-2028

Japan Market by Joint Type (Knee, Shoulder and Elbow, Hip, Foot and Ankle, Other Joint Types) Market by Injection Type (Hyaluronic Acid, Corticosteroid, Other Drugs) Market by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels)

Request free sample

The Japan joint pain injections market is evaluated to develop with a CAGR of 8.57% over the forecast years. The market growth of the country is driven by key factors such as increasing pharmaceutical and biopharmaceutical production, the growing research and development, and the surging prevalence of chronic diseases. The base year considered for the studied market is 2021 and the forecasting period is from 2022 to 2028.

japan-joint-pain-injections-market

To learn more about this report, request a free sample copy

Joint pain injections are characterized as medicinal fluids inserted into the patient’s body to promote faster relief from severe pain. They are also used to reduce inflammation in the joints.

As the third-largest sector, Japan’s pharmaceutical industry is continually engaged in the development of new and innovative products. Moreover, the rising partnerships with several international companies have resulted in significant innovations, thereby providing the country’s market with lucrative growth opportunities.

On the other hand, the penetration of global firms in Japan is set to favor the country’s joint pain injections market growth. For instance, an American biotechnology company Genzyme Corp’s Synvisc, used for the treatment of osteoarthritis of the knee, received approval in Japan. As a result, these factors are set to play a vital role in promoting the market growth in Japan during the forecasting period.

Chugai Pharmaceutical, headquartered in Japan, is actively engaged in the distribution and production of therapeutic platforms for cancer, renal diseases, bone and joint diseases, among others. It has a strong focus on research and development, with nearly 4,900 patents registered in its name. The company’s active business operations span Europe, North America, the Middle East, Latin America, and the Asia-Pacific.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • PESTLE ANALYSIS
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    4. MARKET BY JOINT TYPE
      • KNEE
      • SHOULDER AND ELBOW
      • HIP
      • FOOT AND ANKLE
      • OTHER JOINT TYPES
    5. MARKET BY INJECTION TYPE
      • HYALURONIC ACID
      • CORTICOSTEROID
      • OTHER DRUGS
    6. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITALS PHARMACIES
      • RETAIL PHARMACIES
      • OTHER DISTRIBUTION CHANNELS
    7. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • CHUGAI PHARMACEUTICAL
        • FERRING PHARMACEUTICALS
        • PFIZER INC
        • SANOFI
        • SEIKAGAKU CORPORATION
        • SMITH & NEPHEW PLC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS

    TABLE 2: JAPAN JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: JAPAN JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 4: JAPAN JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: JAPAN JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 6: JAPAN JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: JAPAN JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 8: LIST OF MERGERS & ACQUISITIONS

    TABLE 9: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 10: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 11: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: JAPAN JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021

    FIGURE 6: JAPAN JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2028 (IN $ MILLION)

    FIGURE 7: JAPAN JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2028 (IN $ MILLION)

    FIGURE 8: JAPAN JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2028 (IN $ MILLION)

    FIGURE 9: JAPAN JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2028 (IN $ MILLION)

    FIGURE 10: JAPAN JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2028 (IN $ MILLION)

    FIGURE 11: JAPAN JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021

    FIGURE 12: JAPAN JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2028 (IN $ MILLION)

    FIGURE 13: JAPAN JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2028 (IN $ MILLION)

    FIGURE 14: JAPAN JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2028 (IN $ MILLION)

    FIGURE 15: JAPAN JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021

    FIGURE 16: JAPAN JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2028 (IN $ MILLION)

    FIGURE 17: JAPAN JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2028 (IN $ MILLION)

    FIGURE 18: JAPAN JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2028 (IN $ MILLION)

    1. MARKET BY JOINT TYPE
      • KNEE
      • SHOULDER AND ELBOW
      • HIP
      • FOOT AND ANKLE
      • OTHER JOINT TYPES
    2. MARKET BY INJECTION TYPE
      • HYALURONIC ACID
      • CORTICOSTEROID
      • OTHER DRUGS
    3. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITALS PHARMACIES
      • RETAIL PHARMACIES
      • OTHER DISTRIBUTION CHANNELS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now